NEW YORK, NY / ACCESS Newswire / September 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ:RXST) between November 7, 2024 and July 8, 2025, both dates inclusive (the "Class Period", of the important September 22, 2025 lead plaintiff deadline. SO WHAT: If […]

Edgewise Therapeutics, Inc. (“Edgewise” or the “Company”), (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions, today announced that on August 29, 2025, Edgewise granted inducement stock options to purchase a total of 16,500 shares of Edgewise's common stock to 2 new non-executive employees in connection

NEW YORK CITY, NY / ACCESS Newswire / September 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ:NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October 21, 2025 lead plaintiff deadline. SO

NEW YORK CITY, NY / ACCESS Newswire / September 3, 2025 / WHY: New York, N.Y., September 3, 2025. Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Semler Scientific, Inc. (NASDAQ:SMLR) between March 10, 2021 and April 15, 2025,

NEW YORK CITY, NY / ACCESS Newswire / September 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable Offshore Corp. (NYSE:SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the "Class Period"); and/or (2) pursuant and/or traceable to Sable’s May 21,

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE:SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the "Class Period"), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline.

Robbins Geller Rudman & Dowd LLP announces that the C3.ai class action lawsuit – captioned Liggett v. C3.ai, Inc., No. 25-cv-07129 (N.D. Cal.) – seeks to represent purchasers or acquirers of C3.ai, Inc. (NYSE: AI) securities and charges C3.ai as well as certain of C3.ai's top executives with violations of the Securities Exchange Act of

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Nutex Health Inc. (NASDAQ:NUTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nutex-health-inc-lawsuit-submission-form?prid=165146&wire=1&utm_campaign=7 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Sable Offshore Corp. (NYSE:SOC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sable-offshore-corp-lawsuit-submission-form?prid=165144&wire=1&utm_campaign=1 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

NEW YORK, NY / ACCESS Newswire / September 3, 2025 / If you suffered a loss on your Charter Communications, Inc. (NASDAQ:CHTR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/charter-communications-inc-lawsuit-submission-form?prid=165145&wire=1&utm_campaign=4 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or